Skip to content

Clinical trials

Phase 3 Lung Neoplasms trials in Romania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 3 Country / region: Romania Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20091
20101
20152
20161
20201
20211
20222
20232
20243
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting7
Active, not recruiting5
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
Amgen2
Bristol-Myers Squibb2
Eli Lilly and Company2
AstraZeneca1
BioNTech SE1
Genentech, Inc.1
GlaxoSmithKline1
Gustave Roussy, Cancer Campus, Grand Paris1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms22
Carcinoma, Non-Small-Cell Lung16
Carcinoma3
Neoplasms3
Lung Diseases2
Small Cell Lung Carcinoma2
Anemia1
Bronchial Neoplasms1
Carcinoma, Bronchogenic1
Neoplasm Metastasis1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.